1. Home
  2. DLB vs APGE Comparison

DLB vs APGE Comparison

Compare DLB & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolby Laboratories

DLB

Dolby Laboratories

HOLD

Current Price

$61.39

Market Cap

5.8B

Sector

Miscellaneous

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$83.98

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLB
APGE
Founded
1965
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.7B
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
DLB
APGE
Price
$61.39
$83.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
13
Target Price
$90.75
$109.67
AVG Volume (30 Days)
550.1K
1.1M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
2.33%
N/A
EPS Growth
N/A
N/A
EPS
0.55
N/A
Revenue
N/A
N/A
Revenue This Year
$6.22
N/A
Revenue Next Year
$3.84
N/A
P/E Ratio
$112.35
N/A
Revenue Growth
N/A
N/A
52 Week Low
$57.62
$26.20
52 Week High
$78.28
$85.94

Technical Indicators

Market Signals
Indicator
DLB
APGE
Relative Strength Index (RSI) 49.83 63.94
Support Level $60.14 $73.06
Resistance Level $67.93 N/A
Average True Range (ATR) 1.36 4.45
MACD 0.27 1.19
Stochastic Oscillator 82.37 91.17

Price Performance

Historical Comparison
DLB
APGE

About DLB Dolby Laboratories

Dolby Laboratories Inc. develops technologies that enhance audio and video capture, transmission, and playback, enabling high-quality experiences across movies, TV, music, sports, and more. The company designs and manufactures audio, imaging, accessibility, and related hardware and software mainly for cinema, including digital cinema servers and media encryption and packaging tools. It generates the majority of its revenue by licensing its technology, brand, and patents to device manufacturers and by selling cinema hardware and services. It operates as a single reportable segment, with revenue derived mainly from licensing and, to a lesser extent, from premium cinema technologies, across the United States and international markets.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: